schliessen

Filtern

 

Bibliotheken

APE1 overexpression is associated with poor survival in patients with solid tumors: a meta-analysis.

APE1 is known as a key mediator of DNA damage repair pathways, and its clinical significance in different types of cancer is well studied. Herein, we performed a meta-analysis to determine the association of APE1 expression and survival in different types of solid cancer. We searched all eligible pu... Full description

Journal Title: Oncotarget August 29, 2017, Vol.8(35), pp.59720-59728
Main Author: Yuan, Chun-Ling
Other Authors: He, Fan , Ye, Jia-Zhou , Wu, Hui-Ni , Zhang, Jin-Yan , Liu, Zhi-Hui , Li, Yong-Qiang , Luo, Xiao-Ling , Lin, Yan , Liang, Rong
Format: Electronic Article Electronic Article
Language: English
Subjects:
Ihc
ID: E-ISSN: 1949-2553 ; DOI: 10.18632/oncotarget.19814
Link: http://search.proquest.com/docview/1942698547/?pq-origsite=primo
Zum Text:
SendSend as email Add to Book BagAdd to Book Bag
Staff View
recordid: proquest1942698547
title: APE1 overexpression is associated with poor survival in patients with solid tumors: a meta-analysis.
format: Article
creator:
  • Yuan, Chun-Ling
  • He, Fan
  • Ye, Jia-Zhou
  • Wu, Hui-Ni
  • Zhang, Jin-Yan
  • Liu, Zhi-Hui
  • Li, Yong-Qiang
  • Luo, Xiao-Ling
  • Lin, Yan
  • Liang, Rong
subjects:
  • Ape1
  • Ihc
  • Meta-Analysis
  • Prognosis
ispartof: Oncotarget, August 29, 2017, Vol.8(35), pp.59720-59728
description: APE1 is known as a key mediator of DNA damage repair pathways, and its clinical significance in different types of cancer is well studied. Herein, we performed a meta-analysis to determine the association of APE1 expression and survival in different types of solid cancer. We searched all eligible publications in PubMed, Web of Science and Embase platforms from inception to January 2017 and found 15 relevant manuscripts. Overall survival (OS), 12- and 36-month survival rates, and hazard ratios (HRs) were extracted and analyzed. Heterogeneity and publication bias were also assessed. A subgroup analysis of the different subcellular locations of APE1 was also conducted. Patients with higher APE1 levels demonstrated lower 12- and 36-month survival rates than those with low APE1 levels (HR 2.00, 95% CI 1.33–3.00, P = 0.0009; HR 1.84, 95% CI 1.19–2.84, P = 0.006). Importantly, the pooled analysis showed that high levels of APE1 predict shorter OS (HR 1.44, 95% CI 1.13–1.83, P = 0.003). Subgroup analysis revealed that both nuclear and cytoplasmic expression levels of APE1 are important indicators of poor prognosis in solid tumors.
language: eng
source:
identifier: E-ISSN: 1949-2553 ; DOI: 10.18632/oncotarget.19814
fulltext: fulltext
issn:
  • 19492553
  • 1949-2553
url: Link


@attributes
ID498947186
RANK0.07
NO1
SEARCH_ENGINEprimo_central_multiple_fe
SEARCH_ENGINE_TYPEPrimo Central Search Engine
LOCALfalse
PrimoNMBib
record
control
sourcerecordid1942698547
sourceidproquest
recordidTN_proquest1942698547
sourcesystemPC
pqid1942698547
display
typearticle
titleAPE1 overexpression is associated with poor survival in patients with solid tumors: a meta-analysis.
creatorYuan, Chun-Ling ; He, Fan ; Ye, Jia-Zhou ; Wu, Hui-Ni ; Zhang, Jin-Yan ; Liu, Zhi-Hui ; Li, Yong-Qiang ; Luo, Xiao-Ling ; Lin, Yan ; Liang, Rong
contributorYuan, Chun-Ling (correspondence author) ; Yuan, Chun-Ling (record owner)
ispartofOncotarget, August 29, 2017, Vol.8(35), pp.59720-59728
identifierE-ISSN: 1949-2553 ; DOI: 10.18632/oncotarget.19814
subjectApe1 ; Ihc ; Meta-Analysis ; Prognosis
languageeng
source
descriptionAPE1 is known as a key mediator of DNA damage repair pathways, and its clinical significance in different types of cancer is well studied. Herein, we performed a meta-analysis to determine the association of APE1 expression and survival in different types of solid cancer. We searched all eligible publications in PubMed, Web of Science and Embase platforms from inception to January 2017 and found 15 relevant manuscripts. Overall survival (OS), 12- and 36-month survival rates, and hazard ratios (HRs) were extracted and analyzed. Heterogeneity and publication bias were also assessed. A subgroup analysis of the different subcellular locations of APE1 was also conducted. Patients with higher APE1 levels demonstrated lower 12- and 36-month survival rates than those with low APE1 levels (HR 2.00, 95% CI 1.33–3.00, P = 0.0009; HR 1.84, 95% CI 1.19–2.84, P = 0.006). Importantly, the pooled analysis showed that high levels of APE1 predict shorter OS (HR 1.44, 95% CI 1.13–1.83, P = 0.003). Subgroup analysis revealed that both nuclear and cytoplasmic expression levels of APE1 are important indicators of poor prognosis in solid tumors.
version4
lds50peer_reviewed
links
openurl$$Topenurl_article
openurlfulltext$$Topenurlfull_article
backlink$$Uhttp://search.proquest.com/docview/1942698547/?pq-origsite=primo$$EView_record_in_ProQuest_(subscribers_only)
search
creatorcontrib
0Yuan, Chun-Ling
1He, Fan
2Ye, Jia-Zhou
3Wu, Hui-Ni
4Zhang, Jin-Yan
5Liu, Zhi-Hui
6Li, Yong-Qiang
7Luo, Xiao-Ling
8Lin, Yan
9Liang, Rong
titleAPE1 overexpression is associated with poor survival in patients with solid tumors: a meta-analysis.
subject
0Ape1
1Ihc
2Meta-Analysis
3Prognosis
4APE1
5IHC
6meta-analysis
7prognosis
general
0English
110.18632/oncotarget.19814
2MEDLINE (ProQuest)
3ProQuest Biological Science Collection
4ProQuest Natural Science Collection
5ProQuest SciTech Collection
6Biological Science Database
7Natural Science Collection
8SciTech Premium Collection
9Health Research Premium Collection
10Health Research Premium Collection (Alumni edition)
11Biological Science Index (ProQuest)
sourceidproquest
recordidproquest1942698547
issn
019492553
11949-2553
rsrctypearticle
creationdate2017
addtitleOncotarget
searchscope
01007527
11007944
21009130
310000004
410000038
510000050
610000120
710000159
810000238
910000253
1010000260
1110000270
1210000271
1310000302
1410000350
15proquest
scope
01007527
11007944
21009130
310000004
410000038
510000050
610000120
710000159
810000238
910000253
1010000260
1110000270
1210000271
1310000302
1410000350
15proquest
lsr43
01007527false
11007944false
21009130false
310000004false
410000038false
510000050false
610000120false
710000159false
810000238false
910000253false
1010000260false
1110000270false
1210000271false
1310000302false
1410000350false
contributorYuan, Chun-Ling
startdate20170829
enddate20170829
citationpf 59720 pt 59728 vol 8 issue 35
lsr30VSR-Enriched:[pqid, description]
sort
titleAPE1 overexpression is associated with poor survival in patients with solid tumors: a meta-analysis.
authorYuan, Chun-Ling ; He, Fan ; Ye, Jia-Zhou ; Wu, Hui-Ni ; Zhang, Jin-Yan ; Liu, Zhi-Hui ; Li, Yong-Qiang ; Luo, Xiao-Ling ; Lin, Yan ; Liang, Rong
creationdate20170829
lso0120170829
facets
frbrgroupid6845510000649386514
frbrtype5
newrecords20181218
languageeng
creationdate2017
topic
0Ape1
1Ihc
2Meta-Analysis
3Prognosis
collection
0MEDLINE (ProQuest)
1ProQuest Biological Science Collection
2ProQuest Natural Science Collection
3ProQuest SciTech Collection
4Biological Science Database
5Natural Science Collection
6SciTech Premium Collection
7Health Research Premium Collection
8Health Research Premium Collection (Alumni edition)
9Biological Science Index (ProQuest)
prefilterarticles
rsrctypearticles
creatorcontrib
0Yuan, Chun-Ling
1He, Fan
2Ye, Jia-Zhou
3Wu, Hui-Ni
4Zhang, Jin-Yan
5Liu, Zhi-Hui
6Li, Yong-Qiang
7Luo, Xiao-Ling
8Lin, Yan
9Liang, Rong
jtitleOncotarget
toplevelpeer_reviewed
delivery
delcategoryRemote Search Resource
fulltextfulltext
addata
aulast
0Yuan
1He
2Ye
3Wu
4Zhang
5Liu
6Li
7Luo
8Lin
9Liang
aufirst
0Chun-Ling
1Fan
2Jia-Zhou
3Hui-Ni
4Jin-Yan
5Zhi-Hui
6Yong-Qiang
7Xiao-Ling
8Yan
9Rong
au
0Yuan, Chun-Ling
1He, Fan
2Ye, Jia-Zhou
3Wu, Hui-Ni
4Zhang, Jin-Yan
5Liu, Zhi-Hui
6Li, Yong-Qiang
7Luo, Xiao-Ling
8Lin, Yan
9Liang, Rong
addauYuan, Chun-Ling
atitleAPE1 overexpression is associated with poor survival in patients with solid tumors: a meta-analysis.
jtitleOncotarget
risdate20170829
volume8
issue35
spage59720
epage59728
pages59720-59728
eissn1949-2553
formatjournal
genrearticle
ristypeJOUR
doi10.18632/oncotarget.19814
urlhttp://search.proquest.com/docview/1942698547/
date2017-08-29
Cannot write session to /tmp/vufind_sessions/sess_ibv6ak64411d4ogtikspk20f23